Evaluation of Iron Levels in Newborns with HIE
DOI:
https://doi.org/10.54112/bcsrj.v6i4.1713Keywords:
HIE, neonates, iron metabolism, serum iron, ferritin, TIBCAbstract
Neonatal hypoxic-ischemic encephalopathy (HIE) is a major cause of mortality and neurodevelopmental disability, particularly in low-resource settings. Iron metabolism may be disrupted in HIE due to oxidative stress and inflammation, potentially affecting neurological outcomes. Objective: To evaluate serum iron levels in newborns with HIE and investigate their association with disease severity and clinical outcomes. Methods: This descriptive cross-sectional study was conducted at Department of Neonatal Medicine, Sindh institute of Child Health and Neonatology Korangi-5, Karachi, July, 2024 to December, 2024. Eighty term neonates with HIE (Sarnat staging) were enrolled within 72 hours of life. Serum iron, ferritin, and total iron-binding capacity (TIBC) were measured, and their relationship with HIE severity and Apgar scores was analyzed using SPSS version 25. Results: Neonates with severe HIE (Stage III) had significantly lower serum iron (59.1 ± 11.4 µg/dL) and ferritin levels, and higher TIBC compared to milder stages (p < 0.01). Lower Apgar scores correlated with reduced iron levels. Conclusion: Severe HIE is associated with altered iron metabolism, suggesting a potential role for iron as a biomarker. Cautious iron management may improve outcomes, warranting further research.
Downloads
References
Zhang, J., Rao, X., Li, Y., Zhu, Y., Liu, F., Guo, G., Luo, G., Meng, Z., De Backer, D., Xiang, H. and Peng, Z., 2021. Pilot trial of high-dose vitamin C in critically ill COVID-19 patients. Annals of intensive care, 11, pp.1-12.
JamaliMoghadamSiahkali, S., Zarezade, B., Koolaji, S., SeyedAlinaghi, S., Zendehdel, A., Tabarestani, M., Sekhavati Moghadam, E., Abbasian, L., Dehghan Manshadi, S.A., Salehi, M. and Hasannezhad, M., 2021. Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial. European journal of medical research, 26, pp.1-9.
Sun, L., Zhao, J.H., Fan, W.Y., Feng, B., Liu, W.W., Chen, R.Q., Ban, C., Dang, A.G., Wang, M., Luo, K.T. and Zhou, G.Y., 2024. Therapeutic effects of high-dose vitamin C supplementation in patients with COVID-19: a meta-analysis. Nutrition Reviews, 82(8), pp.1056-1068.
Corrao, S., Raspanti, M., Agugliaro, F., Gervasi, F., Di Bernardo, F., Natoli, G. and Argano, C., 2024. Safety of high-dose vitamin C in non-intensive care hospitalized patients with COVID-19: an open-label clinical study. Journal of Clinical Medicine, 13(13), p.3987.
Zhao, B., Ling, Y., Li, J., Peng, Y., Huang, J., Wang, Y., Qu, H., Gao, Y., Li, Y., Hu, B. and Lu, S., 2021. Beneficial aspects of high dose intravenous vitamin C on patients with COVID-19 pneumonia in severe condition: a retrospective case series study. Annals of palliative medicine, 10(2), pp.1599609-1591609.
Vollbracht, C. and Kraft, K., 2022. Oxidative stress and hyper-inflammation as major drivers of severe COVID-19 and long COVID: implications for the benefit of high-dose intravenous vitamin C. Frontiers in Pharmacology, 13, p.899198.
Gavrielatou, E., Xourgia, E., Xixi, N.A., Mantelou, A.G., Ischaki, E., Kanavou, A., Zervakis, D., Routsi, C., Kotanidou, A. and Siempos, I.I., 2022. Effect of vitamin C on clinical outcomes of critically ill patients with COVID-19: an observational study and subsequent meta-analysis. Frontiers in Medicine, 9, p.814587.
Gao, D., Xu, M., Wang, G., Lv, J., Ma, X., Guo, Y., Zhang, D., Yang, H., Jiang, W., Deng, F. and Xia, G., 2021. The efficiency and safety of high-dose vitamin C in patients with COVID-19: a retrospective cohort study. Aging (Albany NY), 13(5), p.7020.
Bhowmik, K.K., Barek, M.A., Aziz, M.A. and Islam, M.S., 2022. Impact of high‐dose vitamin C on the mortality, severity, and duration of hospital stay in COVID‐19 patients: A meta‐analysis. Health Science Reports, 5(5), p.e762.
Labbani-Motlagh, Z., Amini, S., Aliannejad, R., Sadeghi, A., Shafiee, G., Heshmat, R., Jafary, M., Talaschian, M., Akhtari, M., Jamshidi, A. and Mahmoudi, M., 2022. High-dose intravenous vitamin C in early stages of severe acute respiratory syndrome coronavirus 2 infection: a double-blind, randomized, controlled clinical trial. Journal of Research in Pharmacy Practice, 11(2), pp.64-72.
Majidi, N., Rabbani, F., Gholami, S., Gholamalizadeh, M., BourBour, F., Rastgoo, S., Hajipour, A., Shadnoosh, M., Akbari, M.E., Bahar, B. and Ashoori, N., 2021. The effect of vitamin C on pathological parameters and survival duration of critically ill coronavirus disease 2019 patients: a randomized clinical trial. Frontiers in immunology, 12, p.717816.
Hess, A.L., Halalau, A., Dokter, J.J., Paydawy, T.S., Karabon, P., Bastani, A., Baker, R.E., Balla, A.K. and Galens, S.A., 2022. High-dose intravenous vitamin C decreases rates of mechanical ventilation and cardiac arrest in severe COVID-19. Internal and emergency medicine, 17(6), pp.1759-1768.
Mahmoodpoor, A., Shadvar, K., Sanaie, S., Hadipoor, M.R., Pourmoghaddam, M.A. and Saghaleini, S.H., 2021. Effect of Vitamin C on mortality of critically ill patients with severe pneumonia in intensive care unit: a preliminary study. BMC infectious diseases, 21, pp.1-7.
Juneja, D., Gupta, A., Kataria, S. and Singh, O., 2022. Role of high dose vitamin C in management of hospitalised COVID-19 patients: A minireview. World Journal of Virology, 11(5), p.300.
Suna, K., Melahat, U.Ş., Murat, Y., Figen, Ö.E. and Ayperi, Ö., 2022. Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia. Medicina Clínica (English Edition), 158(8), pp.356-360.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Irfan Ali
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
